Merz Pharmaceuticals
Merz Pharmaceuticals
Explore linked clinical trials.2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Active, not recruiting | Phase 3 | 2026-07-01 | NCT04075981 | |
| IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction | Provoked Vestibulodynia | Recruiting | Phase 2 | 2026-03-23 | NCT07486830 |